- Home
- ATOS vs KVHI Comparison
ATOS vs KVHI Comparison
Compare ATOS & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- KVHI
- Stock Information
- Founded
- ATOS 2009
- KVHI 1978
- Country
- ATOS United States
- KVHI United States
- Employees
- ATOS N/A
- KVHI N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- KVHI Radio And Television Broadcasting And Communications Equipment
- Sector
- ATOS Health Care
- KVHI Technology
- Exchange
- ATOS Nasdaq
- KVHI Nasdaq
- Market Cap
- ATOS 96.8M
- KVHI 100.2M
- IPO Year
- ATOS 2012
- KVHI 1996
- Fundamental
- Price
- ATOS $0.89
- KVHI $5.02
- Analyst Decision
- ATOS Strong Buy
- KVHI
- Analyst Count
- ATOS 3
- KVHI 0
- Target Price
- ATOS $7.13
- KVHI N/A
- AVG Volume (30 Days)
- ATOS 611.2K
- KVHI 23.6K
- Earning Date
- ATOS 05-13-2025
- KVHI 05-07-2025
- Dividend Yield
- ATOS N/A
- KVHI N/A
- EPS Growth
- ATOS N/A
- KVHI N/A
- EPS
- ATOS N/A
- KVHI N/A
- Revenue
- ATOS N/A
- KVHI $109,975,000.00
- Revenue This Year
- ATOS N/A
- KVHI $4.22
- Revenue Next Year
- ATOS N/A
- KVHI $13.27
- P/E Ratio
- ATOS N/A
- KVHI N/A
- Revenue Growth
- ATOS N/A
- KVHI N/A
- 52 Week Low
- ATOS $0.55
- KVHI $4.17
- 52 Week High
- ATOS $1.74
- KVHI $6.16
- Technical
- Relative Strength Index (RSI)
- ATOS 64.44
- KVHI 47.56
- Support Level
- ATOS $0.78
- KVHI $4.98
- Resistance Level
- ATOS $0.92
- KVHI $5.43
- Average True Range (ATR)
- ATOS 0.06
- KVHI 0.19
- MACD
- ATOS 0.01
- KVHI 0.01
- Stochastic Oscillator
- ATOS 81.82
- KVHI 18.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.